146 related articles for article (PubMed ID: 11818008)
1. Fluorescence spectroscopy as a biomarker in a cell culture and in a nonhuman primate model for ovarian cancer chemopreventive agents.
Brewer M; Utzinger U; Li Y; Atkinson EN; Satterfield W; Auersperg N; Richards-Kortum R; Follen M; Bast R
J Biomed Opt; 2002 Jan; 7(1):20-6. PubMed ID: 11818008
[TBL] [Abstract][Full Text] [Related]
2. Biomarker modulation in a nonhuman rhesus primate model for ovarian cancer chemoprevention.
Brewer M; Utzinger U; Satterfield W; Hill L; Gershenson D; Bast R; Wharton JT; Richards-Kortum R; Follen M
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):889-93. PubMed ID: 11489756
[TBL] [Abstract][Full Text] [Related]
3. Combination of 4-HPR and oral contraceptive in monkey model of chemoprevention of ovarian cancer.
Brewer M; Ranger-Moore J; Satterfield W; Hao Z; Wang J; Brewer E; Wharton JT; Bast R; Zou C
Front Biosci; 2007 Jan; 12():2260-8. PubMed ID: 17127462
[TBL] [Abstract][Full Text] [Related]
4. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
Brewer M; Wharton JT; Wang J; McWatters A; Auersperg N; Gershenson D; Bast R; Zou C
Gynecol Oncol; 2005 Aug; 98(2):182-92. PubMed ID: 15907982
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide.
Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT
Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458
[TBL] [Abstract][Full Text] [Related]
6. Rhesus macaque model for ovarian cancer chemoprevention.
Brewer M; Baze W; Hill L; Utzinger U; Wharton JT; Follen M; Khan-Dawood F; Satterfield W
Comp Med; 2001 Oct; 51(5):424-9. PubMed ID: 11924802
[TBL] [Abstract][Full Text] [Related]
7. Endogenous fluorescence spectroscopy of cell suspensions for chemopreventive drug monitoring.
Kirkpatrick ND; Zou C; Brewer MA; Brands WR; Drezek RA; Utzinger U
Photochem Photobiol; 2005; 81(1):125-34. PubMed ID: 15535738
[TBL] [Abstract][Full Text] [Related]
8. 4-HPR modulates gene expression in ovarian cells.
Brewer M; Kirkpatrick ND; Wharton JT; Wang J; Hatch K; Auersperg N; Utzinger U; Gershenson D; Bast R; Zou C
Int J Cancer; 2006 Sep; 119(5):1005-13. PubMed ID: 16570282
[TBL] [Abstract][Full Text] [Related]
9. In vivo native fluorescence spectroscopy and nicotinamide adinine dinucleotide/flavin adenine dinucleotide reduction and oxidation states of oral submucous fibrosis for chemopreventive drug monitoring.
Sivabalan S; Vedeswari CP; Jayachandran S; Koteeswaran D; Pravda C; Aruna PR; Ganesan S
J Biomed Opt; 2010; 15(1):017010. PubMed ID: 20210484
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.
Kalemkerian GP; Slusher R; Ramalingam S; Gadgeel S; Mabry M
J Natl Cancer Inst; 1995 Nov; 87(22):1674-80. PubMed ID: 7473815
[TBL] [Abstract][Full Text] [Related]
11. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
Colombo N; Formelli F; Cantù MG; Parma G; Gasco M; Argusti A; Santinelli A; Montironi R; Cavadini E; Baglietto L; Guerrieri-Gonzaga A; Viale G; Decensi A
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1914-9. PubMed ID: 17035399
[TBL] [Abstract][Full Text] [Related]
12. N-(4-hydroxyphenyl)retinamide prevents development of T-lymphomas in AKR/J mice.
Chan LN; Zhang S; Cloyd M; Chan TS
Anticancer Res; 1997; 17(1A):499-503. PubMed ID: 9066702
[TBL] [Abstract][Full Text] [Related]
13. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL).
Faderl S; Lotan R; Kantarjian HM; Harris D; Van Q; Estrov Z
Leuk Res; 2003 Mar; 27(3):259-66. PubMed ID: 12537979
[TBL] [Abstract][Full Text] [Related]
14. Multiphoton FLIM imaging of NAD(P)H and FAD with one excitation wavelength.
Cao R; Wallrabe H; Periasamy A
J Biomed Opt; 2020 Jan; 25(1):1-16. PubMed ID: 31920048
[TBL] [Abstract][Full Text] [Related]
15. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016
[TBL] [Abstract][Full Text] [Related]
16. N-(4-hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells.
Herbert BS; Sanders BG; Kline K
Nutr Cancer; 1999; 34(2):121-32. PubMed ID: 10578478
[TBL] [Abstract][Full Text] [Related]
17. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
Simeone AM; Colella S; Krahe R; Johnson MM; Mora E; Tari AM
Carcinogenesis; 2006 Mar; 27(3):568-77. PubMed ID: 16199439
[TBL] [Abstract][Full Text] [Related]
18. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
19. Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?
Cazzaniga M; Varricchio C; Montefrancesco C; Feroce I; Guerrieri-Gonzaga A
J Biomed Biotechnol; 2012; 2012():172897. PubMed ID: 22500077
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Two-Photon Excited Fluorescence Imaging Characterizes Neuron and Astrocyte Metabolic Responses to Manganese Toxicity.
Stuntz E; Gong Y; Sood D; Liaudanskaya V; Pouli D; Quinn KP; Alonzo C; Liu Z; Kaplan DL; Georgakoudi I
Sci Rep; 2017 Apr; 7(1):1041. PubMed ID: 28432298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
